Florian Huber is a Research Associate at Paracelsus Medical University's Institute of Pharmacology and Toxicology, investigating molecular mechanisms of genetic hearing disorders. His work focuses on ubiquitin-proteasome regulation of pendrin (SLC26A4) variants associated with Pendred syndrome. Recent studies demonstrate how proteasome inhibitors rescue function of pathogenic pendrin mutants, offering therapeutic pathways for hearing restoration. Huber develops experimental and computational approaches to map degradation pathways of membrane transport proteins. He supervises medical doctoral candidates and teaches pharmacology in graduate programs.
Christian Friedrich Wilhelm Becker is a full Professor at the University of Vienna, holding a position within the Faculty of Chemistry and the Department of Biological Chemistry. His research profile shows extensive activity in protein chemistry and biochemistry, with particular focus on post-translational modifications and their implications in disease mechanisms. His work bridges chemical biology, biochemistry, and biomedical applications, contributing significantly to the academic and research landscape at one of Europe's oldest and most prestigious universities. Faculty of Chemistry, University of Vienna Department of Biological Chemistry Active research leader with numerous ongoing projects Significant publication record spanning multiple disciplines Professor Becker's research primarily focuses on protein chemistry, particularly post-translational modifications and their role in protein function and dysfunction. His work spans multiple interconnected areas including ubiquitination, protein aggregation, prion protein behavior, and biomimetic approaches to protein analysis. His research has significant implications for understanding neurodegenerative diseases and developing novel therapeutic approaches. The fingerprint analysis of his work shows strong connections to biochemistry, molecular biology, and chemistry, with particular emphasis on cysteine chemistry, glycosylation, and amino acid modifications. Analysis of Professor Becker's recent publications (2021-2025) reveals a consistent research trajectory focused on protein modification techniques and their biological implications. His work shows increasing sophistication in chemical biology approaches to study protein function, with particular emphasis on ubiquitination pathways and protein aggregation mechanisms. The integration of chemical synthesis methods with biological analysis represents a hallmark of his research approach. His publications span high-impact journals in biochemistry, chemical biology, and peptide science, demonstrating the interdisciplinary nature of his contributions. Professor Becker has received notable recognition for his research contributions, most prominently the Cathay Award in 2020. This award acknowledges his significant contributions to the field of protein chemistry and chemical biology. His work appears to have practical applications in therapeutic development, particularly in the areas of targeted protein degradation and immunotherapy, which likely contributed to this recognition. Cathay Award (2020) Professor Becker leads multiple significant research projects, including 'Targeted protein degradation - from small molecules to complex organelles' (2020-2024), 'Taktira: Development of an improved, low-side-effect and sustainable immunotherapy' (2019-2023), and 'Structure Zoom: Zooming in on protein functional sites with atomic resolution' (2018-2021). These projects demonstrate substantial grant funding and collaborative research efforts across multiple institutions. His active participation in 290 recorded activities through 2025 indicates a highly engaged research program with numerous collaborators and trainees. Targeted protein degradation project (2020-2024) Taktira immunotherapy project (2019-2023) Structure Zoom project (2018-2021) Professor Becker's research environment includes a robust team of collaborators and junior researchers, as evidenced by the numerous co-authored publications and activities. His work intersects with multiple research groups studying protein function, modification, and therapeutic applications. The international collaboration network shown in his profile indicates significant engagement with researchers across multiple countries, creating a dynamic research ecosystem focused on advancing protein science and its biomedical applications.
Professor Marek Sanak serves as Full Professor at the Department of Internal Medicine, Jagiellonian University Medical College in Cracow, Poland. He concurrently holds leadership positions as Acting Director of the Department of Forensic Medicine, Head of the Division of Molecular Biology and Clinical Genetics, and Vice-Rector for Research and International Cooperation since 2016. His academic foundation includes: MD from Jagiellonian University Medical College Specialization in Pediatrics and Genetics PhD from Jagiellonian University Research appointments at Harvard University, University of Paris VI, and University of Zurich Professor Sanak's research integrates clinical genetics with molecular immunology, focusing on asthma pathogenesis, lipid mediators of inflammation, and genetic diagnostics. His laboratory employs advanced techniques including deep DNA/RNA sequencing to identify biomarkers and elucidate disease mechanisms. The work bridges fundamental molecular discoveries with clinical applications in respiratory diseases, allergic disorders, and forensic medicine, demonstrating particular expertise in aspirin-exacerbated respiratory disease and epigenetic regulation of inflammatory pathways. Analysis of his recent publications reveals a strategic evolution from classical asthma research toward molecular genetics and viral pathogenesis. His 2017-2021 work increasingly incorporates epigenetic approaches (DNA methylation, microRNA profiling) while expanding into SARS-CoV-2 research during the pandemic. The publications demonstrate interdisciplinary integration across immunology, respiratory medicine, and molecular diagnostics, with consistent focus on translational applications. His distinguished career has been recognized through numerous honors: The Lancet Investigators Award on Asthma (1997) Polish Ministry of Health Individual Prize (1999) Jagiellonian Laurel (2012) Pro Arte Docendi Award (2014/15) Gold Medal for Long Service (2019) Top 2% of world scientists ranking (Elsevier 2022) As Vice-Rector for Research, Professor Sanak has significantly expanded international collaborations with King's College London, University of Southampton, and University of Zurich. His leadership has secured substantial funding for molecular diagnostics and inflammatory disease research while mentoring numerous early-career researchers. He delivers invited lectures globally for organizations including the American Thoracic Society and European Academy of Allergy and Clinical Immunology. Professor Sanak directs integrated research units across the Division of Molecular Biology and Clinical Genetics, Division of Biochemical and Molecular Diagnostics at University Hospital Cracow, and the Department of Forensic Medicine. These teams combine clinical service with basic research to advance genetic diagnostics and understand disease mechanisms, maintaining forensic genetics expertise developed over 20 years of practice.
Janusz Bujnicki is a Professor and head of the Laboratory of Bioinformatics and Protein Engineering at the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), Poland. He holds concurrent roles in science policy advisory bodies, including the European Commission's Group of Chief Scientific Advisors (2015-2020, then expert) and the Polish Academy of Sciences’ advisory panel (2024-). He is also a founding member of the Association of ERC Grantees (AERG) and serves on the Scientific Advisory Board of Life Science Center at Vilnius University. Academia Europaea Member (2018-) EMBO Member (2018-) Leadership Academy for Poland (2018) His research spans structural biology, RNA modification, computational biology, and molecular evolution. He has pioneered computational methods like ModeRNA, SimRNA, and ClaRNA for RNA structure prediction and analysis, and developed databases like MODOMICS for RNA modification pathways. His work has applications in understanding RNA function and drug design targeting RNA-processing enzymes. The 15 most recent publications focus on RNA structural modeling (e.g., ModeRNA, ClaRNA, SupeRNAlign), RNA-ligand interactions (LigandRNA), and RNA modification biology (MODOMICS database). These works bridge computational methods with experimental validation in RNA enzymology and structure-function relationships. Scientific Awards: ERC Starting Grant (2010), EMBO Member (2018), Crystal Brussels Sprout (2016), Prime Minister’s Award (2014), Knight’s Cross of Polonia Restituta (2014) Grants & Leadership: Founded RNA bioinformatics infrastructure at IIMCB, led EU science policy advisory groups, and organized international research competitions (RNA Puzzles)
Arthur Lesk is a Professor of Biochemistry and Molecular Biology at Pennsylvania State University since 2003. Previously, he held roles including faculty member at the clinical school of the University of Cambridge (1990–2003), group leader at the European Molecular Biology Laboratory (1987–1990), and professor of chemistry at Fairleigh Dickinson University (1971–1987). He earned a B.A. from Harvard University (1961), Ph.D. from Princeton University (1966), and M.Sc. from the University of Cambridge (1999). His research focuses on bioinformatics, genomics, protein structure, and molecular biology. He has authored 189 scientific articles, 10 books, and has an h-index of 61. Notable works include Protein Science (2021) and Introduction to Bioinformatics (2019). Lesk chairs CODATA’s Biological Macromolecules Task Group and is a Fellow of the AAAS and Royal Society of Biology. He maintains active teaching and research roles, delivering lectures globally. His contributions include advancing protein structure databases and computational methods for molecular biology. Lesk is a Life Member of Clare Hall, Cambridge, and has held visiting positions at universities in New Zealand, Australia, and Europe.
Ramesh Shanmughom Pillai is a Full Professor at the Department of Molecular Biology, University of Geneva, Switzerland. He holds additional roles as a Visiting Professor at the University of Kumamoto, Japan, and has been a Group Leader at EMBL Grenoble and a postdoctoral fellow at the Friedrich Miescher Institute. His research focuses on RNA modifications, epigenetics, and piRNA pathways in germline biology. Pillai has received prestigious awards including the ERC Consolidator Grant and The RNA Society Scaringe Award. Education: BSc Botany (University of Kerala, India) MSc Biotechnology (IIT Roorkee, India) PhD in Cell Biology (University of Bern, Switzerland) Research Interests: Pillai’s work centers on RNA biology, particularly the role of RNA modifications (e.g., m6A, m6Am) in development and fertility. He investigates piRNA biogenesis, transposon silencing, and the molecular mechanisms of RNA-protein interactions. His studies bridge biochemistry, genetics, and structural biology to elucidate how RNA molecules regulate critical biological processes. Teaching & Service: At the University of Geneva, he teaches Molecular Biology courses (BSc/MSc levels) and advises 5 PhD students and 4 postdocs. He chairs the ERC Consolidator Grant Review Panel and organizes major conferences like the PIWI/piRNAs Meeting and Swiss RNA Workshop. Pillai also serves on editorial boards for Nucleic Acids Research and RNA . Awards: ERC Consolidator Grant (2015) Best PhD Thesis Award (2003) RNA Society Scaringe Award (2005) Grants & Labs: Funded by ERC Starting and Consolidator Grants, his lab explores RNA modification networks in germ cells. Former trainees include Professors Simon Conn (Flinders University) and Hao Wu (CAS, China).
Henry Jäger is a Professor in Food Technology at the University of Natural Resources and Life Sciences, Vienna (BOKU) since 2014. Previously, he worked as a Project Manager at Nestlé (2012-2014) and Lecturer at TU Berlin (2012-2017), following his PhD/Postdoc at TU Berlin (2006-2012) and Diploma in Food Technology (2000-2006). His research focuses on electrotechnologies in food processing , particularly pulsed electric fields (PEF) and ohmic heating , for microbial inactivation, food preservation, and quality optimization. He explores applications in plant material processing , gluten-free baking , and novel food preservation methods . His work also addresses edible insect processing for allergenicity reduction and protein recovery. Recent publications (2025-2024) analyze synergies between PEF and ohmic heating, biofilm imitation systems for hygiene validation, and computational models for sterilization processes. These studies span food safety , sustainable processing , and functional food design . Henry Jäger actively contributes to scientific communities, serving on the EFFoST managing board , as scientific advisor for food conferences, and as reviewer for journals like Food Chemistry and Trends in Food Science & Technology . He has organized workshops on PEF applications and contributed to EU food technology initiatives.
Fabian Pfrengle is a full Professor of Organic Chemistry at the Institute of Organic Chemistry , Department of Natural Sciences and Sustainable Resources , University of Natural Resources and Life Sciences Vienna (BOKU). He previously led research groups at the Max Planck Institute of Colloids and Interfaces (2013-2020) and worked at The Scripps Research Institute (2010-2013). Research Focus: His work bridges carbohydrate chemistry and plant biology , specializing in plant cell wall glycans and glycosyltransferases . He develops synthetic glycan arrays for enzyme characterization and investigates immune response triggering mechanisms in plants through oligosaccharide fragments . His projects include automated polysaccharide synthesis and liposome-based immune tolerance applications. Publication Trends: His 15 most recent articles emphasize chemical synthesis of sugar nucleotides , plant glycan arrays , and enzyme specificity analysis , reflecting his focus on carbohydrate engineering and plant immunity . Key subfields include UDP-sugar derivatization , Xylan structure-function relationships , and Glycosyltransferase profiling . Grants & Projects: Currently leads 5 major projects including Automated Algal Polysaccharide Synthesis (EU-funded, 2023-2028) and Synthetic Glycan Ligands for Plant Immune Receptors (FWF-funded, 2022-2026). His research also explores thrombocyte biology and Rhamnogalacturonan-II fragments with support from FWF and City of Vienna . Community Service: Serves on editorial boards ( Monatshefte für Chemie , 2021-present) and as reviewer for 12 journals including JACS Au , Nature Communications , and Angewandte Chemie . Member of professional societies: Gesellschaft Österreichischer Chemiker (2020), Deutscher Hochschulverband (2019), and Gesellschaft Deutscher Chemiker (2008).
Martin Fromm is a Professor of Clinical Pharmacology and Toxicology at Friedrich-Alexander University Erlangen-Nürnberg, where he has served as Director of the Institute of Experimental and Clinical Pharmacology and Toxicology since 2004. His career includes prior roles as Acting Professor (2002–2004), Group Leader (1999–2002), and postdoctoral fellowships at the Dr. Margarete-Fischer-Bosch Institute (1992–1996) and Vanderbilt University (1997–1999). Research Focus: Mechanisms of variable drug effects, drug transporters, medication safety, and biomarker development for transporter-mediated drug interactions. Publications: Over 170 original articles and 49 reviews with an h-index of 76 (24,000+ citations). Leadership: Chair of the University Hospital Erlangen's drug utilization committee and steering board of the Center of Clinical Studies. Scientific Awards: Top 3% Highly Cited Researcher (AD Scientific Index 2022–2024) Top 2% Highly Cited Researcher (Stanford List 2023) MSD Health Award (2021) Paul-Martini-Award (2001) Presidential Trainee Award (1998) Research Trends: His recent work integrates metabolomics, machine learning (LC-MS methods), and clinical studies to enhance medication safety in oncology and geriatrics. Earlier studies focus on transporter proteins (e.g., OCT2, MATE1, P-glycoprotein) and their role in drug absorption, metabolism, and interactions. Grants & Collaborations: Funded by DFG, BMBF, BMG, and Deutsche Krebshilfe. Active in ethics committees and clinical pharmacology societies.
Sabine Glasl-Tazreiter is a Lecturer at the University of Vienna's Faculty of Life Sciences , specifically within the Department of Pharmaceutical Sciences and its Division of Pharmacognosy . Her office is located in room 2E 412 on the 4th floor at Josef-Holaubek-Platz 2, Vienna, Austria (1090). Contact details include telephone number +43-1-4277-55207 and email sabine.glasl@univie.ac.at . Principal research focus: Phytochemistry & Biodiscovery Specialization: Secondary metabolites from ethnomedicinally used plants across Europe, Mongolia, and Latin America Key techniques: Isolation of bioactive compounds, structural elucidation, pharmacological evaluation Quality control expertise: Macroscopic/microscopic identification, chemical analytics Recent publications highlight her work in: 2024 - Development of the VOLKSMED Database for Austrian folk medicine wound healing plants 2025 - Advanced mucociliary clearance research in respiratory systems 2023 - Innovations in optoacoustic imaging technology 2019 - Structure-function analysis of phycobiliproteins for medical imaging 2017 - Phytochemical characterization of Latin American antidiabetic plants
Elisa Riedo is a tenured Professor of Chemical and Biomolecular Engineering at New York University (NYU) Tandon School of Engineering, with joint appointments as Professor of Physics in NYU’s College of Arts and Science and as affiliated Professor of Mechanical Engineering at Tandon. She serves as Director of Faculty Development at NYU Tandon and has held prior tenured positions at Georgia Tech (2003–2015) and CUNY ASRC (2015–2018). Her academic career spans over two decades, with a Ph.D. in Physics from the University of Milano (2000) and postdoctoral work at EPFL. Her research focuses on nanotechnology , graphene and 2D materials , and thermal scanning probe lithography (tSPL) , with applications in biomedical diagnostics quantum electronics electromagnetic interference shielding mechanical reinforcement of materials She pioneered tSPL for sustainable nanofabrication and discovered diamene—a single-layer diamond structure from graphene under pressure. Her recent work involves transparent infrared electrodes using silver nanowires (2025) and self-organized graphene stacking domains for quantum technologies (2024). She has secured major grants from National Science Foundation , Department of Defense , and Army Research Office . Scientific honors include: 2023 NYU Tandon Excellence in Research Award 2013 American Physical Society Fellow 2005 CREA Innovation Award Membership in the Academy of Europe (2023) She contributes to editorial boards for journals like 2D Materials and Applications and advises companies such as Mirimus Inc. and SwissLitho AG .
Nikolaus (Nik) Fortelny is a Group Leader in Computational Biology at the University of Salzburg, Austria, where he leads the Computational Systems Biology research group within the Department of Biological Sciences & Medical Biology. His research focuses on understanding biological systems at the molecular level through advanced computational approaches. Dr. Fortelny's research interests include: Computational Systems Biology Multi-omics data integration and analysis Single-cell and spatial biology Machine learning applications in biology Network science approaches to biological regulation Immune system modeling His recent publications demonstrate a strong focus on applying computational approaches to understand complex biological systems, particularly in immunology and cellular regulation. His work often involves collaboration with experimental biologists to generate and analyze large-scale datasets from multi-omics experiments collected at single-cell or spatial resolution. Dr. Fortelny is actively involved in research recruitment and is currently hiring for professor positions in Medical Systems Biology and Animal Physiology at the University of Salzburg, with an application deadline of April 19th, 2025. His group regularly seeks students, PhD candidates, postdocs, and staff scientists to join their team.
Roland Ludwig is an Associate Professor at the Institute of Food Technology, Department of Food Science and Technology, University of Natural Resources and Life Sciences, Vienna (BOKU). He is also the current Senate Chairman at BOKU, demonstrating strong institutional leadership. His research is centered on enzyme technology, biocatalysis, biosensors, and electrochemistry, with a particular focus on oxidoreductases such as cellobiose dehydrogenase (CDH) and lytic polysaccharide monooxygenases (LPMOs), which are crucial in biomass degradation and bioenergy applications. His research interests span food biotechnology, enzyme technology, biocatalysis, biosensors, process engineering, electrochemistry, and nanobiotechnology. He investigates the molecular mechanisms of electron transfer in redox enzymes, their application in biosensors and biofuel cells, and their role in the depolymerization of lignocellulosic biomass. His work integrates biochemical, electrochemical, and structural approaches to understand and engineer enzyme function. The recent publication trends highlight a strong focus on LPMOs and CDHs, with studies on their kinetics, substrate specificity, domain dynamics, electron transfer mechanisms, and engineering for improved stability and activity. These works frequently appear in high-impact journals such as ACS Catalysis and Bioelectrochemistry, reflecting the significance and innovation of his research in biocatalysis and bioelectrochemistry. International DropSens Award for Applied Electroanalytical Chemistry Medal of Honour, Faculty of Food Technology and Biotechnology, University of Zagreb RIZ Genius Award for Innovative Sensor Technology Austrian APART Fellowship INiTS Award 2007 (Life Science) Förderpreis der Österreichischen Gesellschaft für Biotechnologie Roland Ludwig actively supervises students and leads multiple externally funded research projects from FWF and EU, including grants focused on electron transfer in oxidoreductases and the kinetic analysis of oxidative biomass-degrading enzymes. He collaborates with international research groups and is a frequent speaker at major scientific conferences. His research contributes to sustainable bioprocesses, green chemistry, and the development of novel bio-based technologies. He is involved in research teams and collaborative projects such as the FWF-funded Doktoratskolleg "Biomolecular Technology of Proteins" and participates in interdisciplinary initiatives bridging food technology, biotechnology, and materials science. His lab focuses on enzyme characterization, protein engineering, and the development of bioelectrochemical devices.
Peer Bork is a Professor at the European Molecular Biology Laboratory (EMBL) in Heidelberg, where he serves as Strategic Head of Bioinformatics and co-head of the Structural and Computational Biology Unit. He also holds honorary professorships at the University of Würzburg (Germany) and Fudan University (China). Educational background: PhD in Biochemistry (1990) Habilitation in Theoretical Biophysics (1995) Research interests span bioinformatics , systems biology , and microbiome analysis , focusing on functional prediction, comparative genomics, and data integration. His work explores global patterns in microbial communities, including enterotypes, drug-microbiome interactions, and planetary-scale gene fluxes. Scientific impact includes over 550 publications (70+ in Nature , Science , and Cell ) and groundbreaking discoveries like the human gut enterotypes and microbiome-based cancer biomarkers . Key projects include the SPIRE microbiome resource and the TARA Oceans expedition . Honors and leadership: EMBO member (2000) Nature Creative Mentoring Award (2008) ERC Advanced Investigator Grants (2011, 2015) Leopoldina member (2014) Honorary doctorate (University of Utrecht, 2017) Co-founder of 5 biotech companies Collaborative networks include partnerships with institutions in Berlin (Max-Delbrück-Center), Würzburg (Germany), and Shanghai (China), as well as global initiatives like the TREC expedition for environmental microbiome analysis.
Professor Ray Dixon Ray Dixon is a Research Professor and Project Leader at the Department of Molecular Microbiology, John Innes Centre, and co-Director of the CAS-JIC Centre for Excellence in Plant and Microbial Sciences in Beijing/Shanghai. He has been an Honorary Professor at the University of East Anglia's School of Biological Sciences since 1998. His career spans over four decades in bacterial nitrogen fixation research. Education: B.Sc. (Microbiology, University of Reading, 1969), D.Phil. (Microbial Genetics, University of Sussex, 1973). Research Focus: Regulation of biological nitrogen fixation by environmental signals (oxygen/nitrogen/metal availability). His lab pioneers synthetic biology approaches to engineer nitrogen fixation into plants, aiming to enhance sustainable agriculture. Achievements: Elected Fellow of the Royal Society (1999), EMBO Member (1987), recipient of the Adam Kondorosi Award (2019) and Fleming Award (1983). Over 30 years of leadership in international scientific committees and funding panels. Key Contributions: Pioneered understanding of nif gene regulation, discovered novel nitrogenase systems, and developed polyprotein strategies for synthetic biology applications. Collaborates globally through initiatives like CEPAMS and UBNFC.
